Desjardins Global Asset Management Inc. Moderna, Inc. Transaction History
Desjardins Global Asset Management Inc.
- $922 Million
- Q4 2023
A detailed history of Desjardins Global Asset Management Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Desjardins Global Asset Management Inc. holds 1,520 shares of MRNA stock, worth $40,523. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,520
Previous 1,498
1.47%
Holding current value
$40,523
Previous $154,000
1.95%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding MRNA
# of Institutions
856Shares Held
266MCall Options Held
28.5MPut Options Held
34.9M-
Vanguard Group Inc Valley Forge, PA41.7MShares$1.11 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$681 Million0.07% of portfolio
-
Baillie Gifford & CO22.1MShares$589 Million0.48% of portfolio
-
State Street Corp Boston, MA17.3MShares$460 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$237 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...